Finkelstein Y, Vardi J, Kesten M M, Hod I
Department of Neurology, Shaare Zedek Medical Center, Jerusalem, Israel.
Neurotoxicology. 1996 Spring;17(1):291-5.
A 47 year old female dentist suffered from hemiparkinsonism which had started eighteen months earlier and was manifested mainly by resting tremor and cogwheel rigidity. A baseline quantitative urinary mercury excretion was 46 micrograms/day. The patient was treated with chelating agent d-penicillamine for a week. Chelation therapy resulted in clinical improvement of parkinsonism and in dynamic changes in daily urinary mercury excretion with a prompt increase to 79 micrograms/day, a subsequent decline followed by increase in the mercury urinary excretion. After a week chelation therapy was stopped. During a follow-up period of five years, the neurological status remained unchanged after the initial penicillamine-induced improvement. This case may be evidence, therefore, of a rare clinical variant of elemental mercury intoxication associated with parkinsonism, in the absence of most classical neuropsychiatric signs of chronic mercurialism.
一名47岁的女牙医患有偏侧帕金森症,该病始于18个月前,主要表现为静止性震颤和齿轮样强直。基线时尿汞定量排泄为46微克/天。患者接受螯合剂青霉胺治疗一周。螯合疗法使帕金森症临床症状改善,尿汞排泄量出现动态变化,迅速增至79微克/天,随后下降,之后又升高。一周后停止螯合治疗。在五年的随访期内,最初由青霉胺诱导的病情改善后,神经状态保持不变。因此,该病例可能证明了一种罕见的与帕金森症相关的元素汞中毒临床变体,且不存在慢性汞中毒的大多数典型神经精神症状。